FindTrial
Sign In

Prognostic Analysis of Patients With Resectable Pancreatic Ductal Adenocarcinoma Undergoing Radical Surgery in the Context of Obese Cachexia

Prognostic Analysis of Patients With Resectable Pancreatic Ductal Adenocarcinoma Undergoing Radical Surgery in the Context of Obese Cachexia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111797
Enrollment
Unknown
Registered
2025-11-06
Start date
2025-11-06
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic ductal adenocarcinoma

Interventions

Non-cachexia group:None
Obesity Group:None
Cachexia group:None
Overweight Group:None
Underweight Group:None
Normal weight Group:None

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Age >=18 years; 2.Underwent pancreatic resection with curative intent; 3.Histopathological diagnosis of PDAC based on surgical specimens; 4.Availability of access to clinical data and follow-up records;

Exclusion criteria

Exclusion criteria: 1.Missing essential perioperative data required for cachexia assessment, including preoperative imaging, height, weight, or documented weight change within 6 months prior to admission; 2.Received neoadjuvant therapy; 3.Had a diagnosis of secondary pancreatic tumors;

Design outcomes

Primary

MeasureTime frame
Overall Survival;—

Secondary

MeasureTime frame
Pancreatic Fistula ;Delayed gastric emptying;Severe postoperative complications;Chylous fistula;—

Countries

China

Contacts

Public ContactWang Zheng

The First Affiliated Hospital of Xi'an Jiaotong University

wangzheng0923@126.com+86 29 85323899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026